Neuroelectrostimulation in treatment of hyposalivation and xerostomia in Sjögren's syndrome: A salivary pacemaker

Journal of Rheumatology

Volumn 35, Issue 8, 2008, Pages 1489-1494

  Fedele, Stefano ^a   Wolff, Andy ^b   Strietzel, Frank ^c   López, Rafael Martín Granizo ^d   Porter, Stephen R ^a   Konttinen, Yrjö T ^e,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Assuta Hospital   (Israel)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f COXA Hospital for Joint Replacement ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CEVIMELINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PILOCARPINE; SALIVA SUBSTITUTE;

CLINICAL TRIAL; DEVICE; ELECTROSTIMULATION THERAPY; HUMAN; HYPOSALIVATION; NERVE STIMULATION; PACEMAKER; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SJOEGREN SYNDROME; TOOTH IMPLANTATION; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

CLINICAL TRIALS AS TOPIC; DENTAL IMPLANTS, SINGLE-TOOTH; ELECTRIC STIMULATION THERAPY; HUMANS; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 49049119479     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:28-46.
2. Billings RJ, Proskin HM, Moss ME. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol 1996;24:312-6.
3. Schein OD, Hochberg MC, Munoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med 1999;159:1359-63.
4. Amerongen AV, Veerman EC. Saliva - the defender of the oral cavity. Oral Dis 2002;8:12-22.
5. Fox RI, Konttinen Y, Fisher A. Use of muscarinic agonists in the treatment of Sjögren's syndrome. Clin Immunol 2001;101:249-63.
6. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjögren's syndrome. Nat Clin Pract Rheumatol 2006;2:252-61.
7. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-5.
8. Sreebny LM, Banoczy J, Baum BJ. Saliva: Its role in health and disease. Working Group 10 of the Commission on Oral Health, Research and Epidemiology (CORE). Int Dent J 1992;42:291-304.
9. Nayak L, Wolff A, Fedele S, et al. Risk factors of xerostomia in independent community-dwelling older adults: results from the Saliwell project. Oral Biosci Med 2004;1:283-9.
10. Proctor GB, Carpenter GH. Regulation of salivary gland function by autonomic nerves. Auton Neurosci 2007;133:3-18.
11. Jonsson R, Gordon TP, Konttinen YT. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome. Curr Rheumatol Rep 2003;5:311-6.
12. Izumi H, Karita K. Low-frequency subthreshold sympathetic stimulation augments maximal reflex parasympathetic salivary secretion in cats. Am J Physiol 1995;268:R1188-95.
13. Schneyer CA, Hall HD. Comparison of rat salivas evoked by auriculo-temporal and pilocarpine stimulation. Am J Physiol 1965;209:484-8.
14. Steller M, Chou L, Daniels TE. Electrical stimulation of salivary flow on patients with Sjogren's syndrome. J Dent Res 1988;67:1334-7.
15. Talal N, Quinn JH, Daniels TE. The clinical effects of electrostimulation on salivary function of Sjogren's syndrome patients. A placebo controlled study. Rheumatol Int 1992;12:43-5.
16. Weiss WW, Brenman HS, Katz P, Bennett JA. Use of an electric stimulator for the treatment of dry mouth. J Oral Maxillofac Surg 1986;44:845-50.
17. Hargitai IA, Sherman RG, Strother JM. The effects of electrostimulation on parotid saliva flow: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:316-20.
18. Wong RK, Jones GW, Sagar SM, Babjak AF, Whelan T. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:472-80.
19. Schneyer CA, Humphreys-Beher MG, Hall HD, Jirakulsomchok D. Mitogenic activity of rat salivary glands after electrical stimulation of parasympathetic nerves. Am J Physiol 1993;264:G935-8.
20. Strietzel FP, Martín-Granizo R, Fedele S, et al. Electrostimulating device in the management of xerostomia. Oral Dis 2007;13:206-13.
21. Clinical trial titled "Evaluation of an Electro-Stimulator for the Treatment of Xerostomia (GenNarino)", ClinicalTrials.gov Identifier: NCT00509808. [cited 2008 April 21] Available from: http://clinicaltrials.gov/ ct2/show/NCT00509808?term=saliwell&ran k=1